Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 21, 2023; 29(3): 487-502
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.487
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.487
Figure 1 Interplay between coronavirus disease 2019 and metabolic-associated fatty liver disease.
COVID-19: Coronavirus disease 2019; MAFLD: Metabolic-associated fatty liver disease; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
- Citation: Jeeyavudeen MS, Chaudhari R, Pappachan JM, Fouda S. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease. World J Gastroenterol 2023; 29(3): 487-502
- URL: https://www.wjgnet.com/1007-9327/full/v29/i3/487.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i3.487